Is C.H. Robinson (CHRW) Balancing Buybacks With Rising Legal and Amazon-Driven Competitive Pressures?

C.H. Robinson Worldwide, Inc.

C.H. Robinson Worldwide, Inc.

CHRW

0.00

  • In the first quarter of 2026, C.H. Robinson Worldwide reported revenue of US$4,012.93 million and net income of US$147.23 million, while continuing a long-running buyback that has retired 79.30 million shares for about US$6.19 billion since 2007, including 1.23 million shares repurchased this year.
  • At the same time, investors are focused on rising competitive pressure from Amazon’s newly opened supply chain services and legal uncertainty from the Montgomery v. C.H. Robinson Supreme Court case, which together are reshaping perceptions of the company’s risk profile despite ongoing earnings and capital return activity.
  • We’ll now examine how Amazon’s move into third‑party supply chain services could reshape C.H. Robinson’s AI-led efficiency narrative and capital allocation priorities.

The latest GPUs need a type of rare earth metal called Terbium and there are only 30 companies in the world exploring or producing it. Find the list for free.

C.H. Robinson Worldwide Investment Narrative Recap

To own C.H. Robinson today, you have to believe its AI-enabled brokerage model and capital returns can offset rising competitive and legal uncertainty. The key near term catalyst is whether its Lean AI platform can keep costs and service levels attractive as Amazon opens its supply chain network. The biggest current risk is that Amazon’s entry and the Montgomery v. C.H. Robinson case together could compress margins and raise liability costs in ways the recent news has only started to highlight.

The most relevant recent update is the first quarter 2026 earnings release, with revenue of US$4,012.93 million and net income of US$147.23 million. Those results, alongside ongoing buybacks that have retired over 79 million shares for about US$6,188.87 million since 2007, show C.H. Robinson still returning cash while its core operations remain profitable. How well that earnings base holds up against new AI powered competition is likely to shape how investors interpret these capital returns.

Yet beneath the headline earnings and buybacks, investors should also be aware of how a potential shift in legal liability standards could...

C.H. Robinson Worldwide's narrative projects $19.1 billion revenue and $876.4 million earnings by 2029.

Uncover how C.H. Robinson Worldwide's forecasts yield a $195.52 fair value, a 17% upside to its current price.

Exploring Other Perspectives

CHRW 1-Year Stock Price Chart
CHRW 1-Year Stock Price Chart

Some of the lowest ranked analysts were already cautious, assuming revenue growth of only about 1.2 percent a year and earnings of roughly US$646.8 million by 2028, and this new competitive and legal pressure could push their already pessimistic view of C.H. Robinson’s intermediary role even further, which is why it is worth comparing these downside assumptions with more optimistic scenarios before you decide where you stand.

Explore 3 other fair value estimates on C.H. Robinson Worldwide - why the stock might be worth 27% less than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your C.H. Robinson Worldwide research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free C.H. Robinson Worldwide research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate C.H. Robinson Worldwide's overall financial health at a glance.

Interested In Other Possibilities?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

  • Capitalize on the AI infrastructure supercycle with our selection of the 39 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
  • Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
  • AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.